Loading...
OTCMREMI
Market cap1mUSD
Dec 18, Last price  
0.06USD
Name

Remedent Inc

Chart & Performance

D1W1MN
OTCM:REMI chart
P/E
P/S
1.12
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
0.74%
Rev. gr., 5y
-9.27%
Revenues
986k
+14.17%
7,072,3007,393,9486,676,3657,482,26114,639,5418,247,94012,581,7089,687,2922,937,2762,592,5963,616,3552,770,0922,355,7062,699,8551,603,7411,064,4191,029,9061,407,661863,819986,220
Net income
-274k
L-81.64%
-103,428-3,887,302-1,496,049-3,115,513-2,952,915-2,349,915-1,547,175490,483-981,936524,508105,159160,802844,370-54,5912,128,796-854,267-163,100-257,182-1,494,837-274,446
CFO
-131k
L+145.91%
583,730-3,013,455-659,307-2,445,011-880,489232,885-135,226-109,777-946,316-103,939300,568-203,1131,668,96020,327567,618101,5481,721-168,948-53,072-130,512

Profile

Remedent, Inc., through its subsidiaries, researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. It also provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient's teeth. In addition, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice, which enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Further, it provides dental implant solutions and treatment concepts. The company sells its products to dental professionals in approximately 30 countries, including Asia, Europe, the Middle East, Canada, and the United States through its internal sales force and third party distributors. The company was founded in 1986 and is headquartered in Ghent, Belgium.
IPO date
Sep 20, 2001
Employees
3
Domiciled in
BE
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
986
14.17%
864
-38.63%
1,408
36.68%
Cost of revenue
383
358
375
Unusual Expense (Income)
NOPBT
603
506
1,032
NOPBT Margin
61.15%
58.53%
73.34%
Operating Taxes
17
18
23
Tax Rate
2.75%
3.51%
2.27%
NOPAT
586
488
1,009
Net income
(274)
-81.64%
(1,495)
481.24%
(257)
57.68%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
15
22
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
(4,488)
(4,731)
(6,014)
Cash flow
Cash from operating activities
(131)
(53)
(169)
CAPEX
Cash from investing activities
Cash from financing activities
FCF
717
748
493
Balance
Cash
43
105
174
Long term investments
4,460
4,625
5,863
Excess cash
4,454
4,688
5,966
Stockholders' equity
(21,626)
(21,340)
(19,825)
Invested Capital
24,090
24,075
24,075
ROIC
2.44%
2.03%
4.19%
ROCE
24.47%
18.49%
24.29%
EV
Common stock shares outstanding
19,996
19,996
19,996
Price
Market cap
EV
EBITDA
623
531
1,061
EV/EBITDA
Interest
4
7
Interest/NOPBT
0.82%
0.72%